Published in Emerg Infect Dis on May 01, 2011
Plague gives surprises in the first decade of the 21st century in the United States and worldwide. Am J Trop Med Hyg (2013) 1.17
Antibodies for biodefense. MAbs (2011) 1.02
Detection of Rickettsia felis, Rickettsia typhi, Bartonella Species and Yersinia pestis in Fleas (Siphonaptera) from Africa. PLoS Negl Trop Dis (2014) 0.95
Pneumonic plague outbreak, Northern Madagascar, 2011. Emerg Infect Dis (2015) 0.88
Clinical, environmental, and serologic surveillance studies of melioidosis in Gabon, 2012-2013. Emerg Infect Dis (2015) 0.85
Fast and simple detection of Yersinia pestis applicable to field investigation of plague foci. PLoS One (2013) 0.82
Crystallization and preliminary X-ray diffraction analysis of FabG from Yersinia pestis. Acta Crystallogr F Struct Biol Commun (2013) 0.79
Evidence of Yersinia pestis DNA from fleas in an endemic plague area of Zambia. BMC Res Notes (2012) 0.78
Crystallization of the acyl-CoA thioesterase TesB from Yersinia pestis. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.77
Structural Characterisation of the Beta-Ketoacyl-Acyl Carrier Protein Synthases, FabF and FabH, of Yersinia pestis. Sci Rep (2015) 0.77
Discovery of a leptospirosis cluster amidst a pneumonic plague outbreak in a miners' camp in the Democratic Republic of the Congo. Int J Environ Res Public Health (2014) 0.76
Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev (1997) 14.63
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Clinical recognition and management of patients exposed to biological warfare agents. JAMA (1997) 4.67
Plague: past, present, and future. PLoS Med (2008) 3.23
Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet (2003) 2.68
Plague and the human flea, Tanzania. Emerg Infect Dis (2007) 1.71
Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar. Clin Diagn Lab Immunol (1997) 1.53
Chloramphenicol and terramycin in the treatment of pneumonic plague. Am J Med (1953) 1.45
Current epidemiology of human plague in Madagascar. Microbes Infect (2000) 1.44
International meeting on preventing and controlling plague: the old calamity still has a future. Wkly Epidemiol Rec (2006) 1.27
Pneumonic plague cluster, Uganda, 2004. Emerg Infect Dis (2006) 1.15
[Major pulmonary plague outbreak in a mining camp in the Democratic Republic of Congo: brutal awakening of an old scourge]. Med Trop (Mars) (2005) 1.01
Comparison of Yersinia CIN agar and mouse inoculation assay for the diagnosis of plague. Trans R Soc Trop Med Hyg (1997) 0.99
Rapid identification of Pasteurella pestis with fluorescent antibody. I. Production of specific antiserum with whole cell Pasteurella pestis antigen. J Infect Dis (1959) 0.99
[Bubonic plague: the old scourge is alive and well. Inter-regional conference on prevention and control of bubonic plague, April 7-11, 2006, Antananarivo, Madagascar]. Med Trop (Mars) (2007) 0.81
Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med (2014) 28.65
Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med (2014) 16.45
Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science (2004) 5.49
The international Ebola emergency. N Engl J Med (2014) 5.35
Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet (2010) 4.35
Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis (2009) 4.24
Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS One (2007) 4.21
Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis (2007) 3.51
Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med (2006) 3.38
Studies of reservoir hosts for Marburg virus. Emerg Infect Dis (2007) 3.35
Plague: past, present, and future. PLoS Med (2008) 3.23
West African Ebola epidemic after one year--slowing but not yet under control. N Engl J Med (2014) 2.96
Evaluation of Brucella MLVA typing for human brucellosis. J Microbiol Methods (2007) 2.86
Pandemic human viruses cause decline of endangered great apes. Curr Biol (2008) 2.73
Molecular Evidence of Sexual Transmission of Ebola Virus. N Engl J Med (2015) 2.71
Ecology of zoonoses: natural and unnatural histories. Lancet (2012) 2.71
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci U S A (2010) 2.69
Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet (2003) 2.68
The origin of malignant malaria. Proc Natl Acad Sci U S A (2009) 2.67
Brucella microti sp. nov., isolated from the common vole Microtus arvalis. Int J Syst Evol Microbiol (2008) 2.49
A tale of two clades: monkeypox viruses. J Gen Virol (2005) 2.24
Ebola virus disease in the Democratic Republic of Congo. N Engl J Med (2014) 2.19
Plague. Lancet (2007) 2.17
Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. J Infect Dis (2007) 2.09
Brucella inopinata sp. nov., isolated from a breast implant infection. Int J Syst Evol Microbiol (2009) 2.08
Anthrax kills wild chimpanzees in a tropical rainforest. Nature (2004) 2.01
Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg (2005) 1.91
Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol (2002) 1.86
Prediction, assessment of the Rift Valley fever activity in East and Southern Africa 2006-2008 and possible vector control strategies. Am J Trop Med Hyg (2010) 1.81
Brucellosis - regionally emerging zoonotic disease? Croat Med J (2010) 1.60
Slow-onset inhibition of the FabI enoyl reductase from francisella tularensis: residence time and in vivo activity. ACS Chem Biol (2009) 1.53
The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola. PLoS Negl Trop Dis (2011) 1.53
Laboratory-based diagnosis of brucellosis--a review of the literature. Part II: serological tests for brucellosis. Clin Lab (2003) 1.48
Endemic human monkeypox, Democratic Republic of Congo, 2001-2004. Emerg Infect Dis (2007) 1.47
Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks. Am J Trop Med Hyg (2004) 1.45
Recombinase polymerase amplification assay for rapid detection of Francisella tularensis. J Clin Microbiol (2012) 1.42
Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. J Infect Dis (2011) 1.37
Conflict and emerging infectious diseases. Emerg Infect Dis (2007) 1.36
Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa. Eur J Cardiovasc Prev Rehabil (2008) 1.35
Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes. Trop Med Int Health (2015) 1.33
Plague reappearance in Algeria after 50 years, 2003. Emerg Infect Dis (2007) 1.32
Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar. Emerg Infect Dis (2002) 1.29
Isolation of Brucella microti from mandibular lymph nodes of red foxes, Vulpes vulpes, in lower Austria. Vector Borne Zoonotic Dis (2009) 1.29
High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob Agents Chemother (2007) 1.27
Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004. J Infect Dis (2007) 1.27
Population structure of Francisella tularensis. J Bacteriol (2006) 1.27
Detection of the reemerging agent Burkholderia mallei in a recent outbreak of glanders in the United Arab Emirates by a newly developed fliP-based polymerase chain reaction assay. Diagn Microbiol Infect Dis (2006) 1.26
Isolation of Brucella microti from soil. Emerg Infect Dis (2008) 1.26
First isolation and direct evidence for the existence of large small-mammal reservoirs of Leptospira sp. in Madagascar. PLoS One (2010) 1.25
Interspecies transmission of simian foamy virus in a natural predator-prey system. J Virol (2008) 1.25
High variety of different simian T-cell leukemia virus type 1 strains in chimpanzees (Pan troglodytes verus) of the Taï National Park, Côte d'Ivoire. J Virol (2004) 1.22
Epidemiological trends for human plague in Madagascar during the second half of the 20th century: a survey of 20,900 notified cases. Trop Med Int Health (2006) 1.21
Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell Matrix-assisted Laser Desorption/Ionisation mass spectrometric typing. BMC Microbiol (2012) 1.21
Emergence of divergent Zaire ebola virus strains in Democratic Republic of the Congo in 2007 and 2008. J Infect Dis (2011) 1.20
Phylogeography and molecular epidemiology of Yersinia pestis in Madagascar. PLoS Negl Trop Dis (2011) 1.19
Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity. BMC Biotechnol (2009) 1.19
Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694. Antimicrob Agents Chemother (2005) 1.17
Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering. J Mol Biol (2008) 1.16
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol (2013) 1.16
Yersinia pestis in small rodents, Mongolia. Emerg Infect Dis (2011) 1.14
Genetic diversity and phylogenetic relationships of bacteria belonging to the Ochrobactrum-Brucella group by recA and 16S rRNA gene-based comparative sequence analysis. Syst Appl Microbiol (2008) 1.14
Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp. Clin Chem Lab Med (2007) 1.12
Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa. East Afr J Public Health (2010) 1.11
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol (2013) 1.10
Laboratory-based diagnosis of brucellosis--a review of the literature. Part I: Techniques for direct detection and identification of Brucella spp. Clin Lab (2003) 1.10
Specific detection and differentiation of Ochrobactrum anthropi, Ochrobactrum intermedium and Brucella spp. by a multi-primer PCR that targets the recA gene. J Med Microbiol (2008) 1.09
Isolation of potentially novel Brucella spp. from frogs. Appl Environ Microbiol (2012) 1.09
Technical note: a rapid diagnostic test detects plague in ancient human remains: an example of the interaction between archeological and biological approaches (southeastern France, 16th-18th centuries). Am J Phys Anthropol (2008) 1.08
Genotyping of Ochrobactrum anthropi by recA-based comparative sequence, PCR-RFLP, and 16S rRNA gene analysis. FEMS Microbiol Lett (2006) 1.04
Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents. J Antimicrob Chemother (2003) 1.03
Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains. Chemotherapy (2005) 1.03
German Francisella tularensis isolates from European brown hares (Lepus europaeus) reveal genetic and phenotypic diversity. BMC Microbiol (2013) 1.03
Antibodies for biodefense. MAbs (2011) 1.02
A high-affinity macaque antibody Fab with human-like framework regions obtained from a small phage display immune library. Mol Immunol (2004) 1.02
Differential phenotyping of Brucella species using a newly developed semi-automated metabolic system. BMC Microbiol (2010) 1.00
Quantitative analysis of the intramacrophagic Brucella suis proteome reveals metabolic adaptation to late stage of cellular infection. Proteomics (2008) 1.00
Using remote sensing to map the risk of human monkeypox virus in the Congo Basin. Ecohealth (2010) 1.00
Brucella endocarditis in prosthetic valves. Can J Cardiol (2006) 0.99
Coexistence of pathogens in host-seeking and feeding ticks within a single natural habitat in Central Germany. Appl Environ Microbiol (2010) 0.99
Yersinial F1 antigen and the cause of Black Death. Lancet Infect Dis (2004) 0.99
Understanding and managing sanitary risks due to rodent zoonoses in an African city: beyond the Boston Model. Integr Zool (2008) 0.99
Mobile diagnostics in outbreak response, not only for Ebola: a blueprint for a modular and robust field laboratory. Euro Surveill (2015) 0.99
Antibodies against anthrax: mechanisms of action and clinical applications. Toxins (Basel) (2011) 0.99
Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS One (2009) 0.98
Prevalence and genetic diversity of simian immunodeficiency virus infection in wild-living red colobus monkeys (Piliocolobus badius badius) from the Taï forest, Côte d'Ivoire SIVwrc in wild-living western red colobus monkeys. Infect Genet Evol (2007) 0.98
The detection of Brucella spp. using PCR-ELISA and real-time PCR assays. Clin Lab (2004) 0.97
Study on the movement of Rattus rattus and evaluation of the plague dispersion in Madagascar. Vector Borne Zoonotic Dis (2010) 0.95
Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection. J Infect Dis (2007) 0.94
Ecology and geography of human monkeypox case occurrences across Africa. J Wildl Dis (2012) 0.94
[A rapid diagnostic test for plague detects Yersinia pestis F1 antigen in ancient human remains]. C R Biol (2007) 0.94
Detection of Yersinia pestis using real-time PCR in patients with suspected bubonic plague. Mol Cell Probes (2010) 0.94
Development and evaluation of two simple, rapid immunochromatographic tests for the detection of Yersinia pestis antibodies in humans and reservoirs. PLoS Negl Trop Dis (2009) 0.94
No evidence for transmission of SIVwrc from western red colobus monkeys (Piliocolobus badius badius) to wild West African chimpanzees (Pan troglodytes verus) despite high exposure through hunting. BMC Microbiol (2011) 0.93
Clinical and virological characterization of imported cases of Chikungunya fever. Wien Klin Wochenschr (2008) 0.93
Mechanism and inhibition of the FabI enoyl-ACP reductase from Burkholderia pseudomallei. J Antimicrob Chemother (2011) 0.92